Introduction 173 Glycaemic control 174 Dyslipidaemia 177 Hypertension 183 Non-pharmacological means of reducing blood pressure 186 Pharmacological treatment of cardiovascular disease 187 Obesity 188 Conclusion 189 References 189 INTRODUCTION Diabetes…
Introduction 151 History of blood glucose monitoring 152 Monitoring in type 2 diabetes 153 Monitoring options 160 Testing for ketones 167 Other factors that can influence monitoring of diabetes 168…
Introduction 21 Why identify people with type 2 diabetes?22 The oral glucose tolerance test 25 Impaired glucose tolerance and impaired fasting glucose 27 Psychological aspects of diagnosis of type 2…
Introduction 39 The personal meaning of having diabetes 40 SECTION ONE: EMOTION, MOOD AND HOW PEOPLE FEEL Self-efficacy 41 Locus of control 42 Health beliefs 42 Stress and diabetes 44…
Keypoints The heterogeneous and progressive nature of type 2 diabetes presents an ongoing requirement for additional and novel blood glucose-lowering agents. Longer-acting (once daily and once weekly injected) analogs of…
Keypoints In the Wisconsin study [1], proliferative diabetic retinopathy (PDR) occurred in 67% of persons with type 1 diabetes mellitus (T1DM) for 35 or more years. One would therefore expect…
Keypoints Glycemic control is a fundamental part of the management of type 2 diabetes mellitus. Adequate glycemic control is necessary to address acute symptoms and to prevent, defer or reduce…
Keypoints Polyuric diseases have been described for over 3500 years. The name “diabetes” comes from the Greek word for a syphon; the sweet taste of diabetic urine was recognized at…
Keypoints Various skin conditions are associated with diabetes, either type 1 or type 2, the specific chronic complications of the disease, the use of antidiabetic drugs and certain endocrine and…
Keypoints Approximately one in three people with diabetes is affected by distal symmetric polyneuropathy (DPN), which represents a major health problem as it may present with excruciating neuropathic pain and…
